Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Mutations01:39

Mutations

82.3K
Overview
82.3K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Cancer Prevention02:59

Cancer Prevention

6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RETRACTED: Sharad et al. Analysis of <i>PMEPA1</i> Isoforms (<i>a</i> and <i>b</i>) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer. <i>Cancers</i> 2019, <i>11</i>, 1995.

Cancers·2026
Same author

Decoding testicular germ cell tumors: integrating risk, biology, and biomarkers into future care.

Gene·2026
Same author

A thyroid storm causing strokes and unmasking moyamoya.

Radiology case reports·2025
Same author

Ten-Year Trends in Digital Rectal Exam Results and Prostate Cancer Detection: Insights from the PLCO Trial.

Research and reports in urology·2025
Same author

Understanding Racial Disparities in Prostate Cancer: A Multifaceted Approach.

Cancer medicine·2025
Same author

Ancestry-Specific DNA Damage Repair Gene Mutations and Prostate Cancer.

Cancers·2025

Related Experiment Video

Updated: Jul 5, 2025

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.4K

Germline Mutations and Ancestry in Prostate Cancer.

Eudoxie Bataba1, Kevin Babcock1, Kathryn A Isensee2

  • 1Walter Reed National Military Medical Center, Bethesda, MD, 20889, USA.

Current Oncology Reports
|January 24, 2024
PubMed
Summary

Prostate cancer incidence varies by ancestry, with higher rates in men of African descent. Genetic databases lack diversity, impacting accurate genetic counseling for all patients.

Keywords:
AncestryDNA damage repairGermline mutationProstate cancer

More Related Videos

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.3K
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

8.7K

Related Experiment Videos

Last Updated: Jul 5, 2025

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.4K
gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.3K
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

8.7K

Area of Science:

  • Oncology
  • Genetics
  • Population Health

Background:

  • Prostate cancer is a leading non-cutaneous malignancy in men, with incidence varying significantly across ancestral groups.
  • Germline mutations in DNA damage repair genes (DDRGs) are recognized contributors to prostate cancer development.
  • Genetic testing for DDRG mutations is increasingly utilized in clinical practice.

Purpose of the Study:

  • To review the impact of ancestry on prostate cancer risk and genetic findings.
  • To highlight the challenges posed by a lack of diversity in genomic databases.
  • To discuss implications for genetic counseling and clinical practice.

Main Methods:

  • Literature review focusing on prostate cancer, ancestry, and genetic databases.
  • Analysis of current guidelines and clinical practices regarding genetic testing.
  • Discussion of the impact of data diversity on patient care.

Main Results:

  • Ancestral disparities in prostate cancer-associated DDRG germline mutations are evident.
  • Current genetic testing panels and counseling practices are largely based on European ancestry data.
  • Lack of diversity in databases hinders discovery of ancestry-specific alterations and accurate risk assessment.

Conclusions:

  • Addressing the lack of diversity in genomic databases is crucial for equitable prostate cancer care.
  • Improved ancestry-informed genetic risk assessment and counseling are needed.
  • Further research is required to understand and target ancestry-specific genetic alterations in prostate cancer.